top of page

Harbinger Venture Capital

Venture Capital

聯訊創投

Search

Eureka Therapeutics is selected 2022 Red Herring Top 100 Global Winners

website2646

Dec 12, 20221 min read

https://smex-ctp.trendmicro.com:443/wis/clicktime/v1/query?url=https%3a%2f%2fwww.redherring.com%2fevents%2fred%2dherring%2dglobal%2f2022%2dred%2dherring%2dtop%2d100%2dglobal%2dwinners%2f&umid=a90cffe6-d81f-46ca-90b9-0b8ca2cb11de&auth=97223b778554cb1c2112fb883bc8e58eb5973272-88c21f9d0efa3494b815c0f7ee40f42a1ba1766c

Recent Posts

BlossomHill Therapeutics Doses Patients in the First Cohort of the Phase 1/2 SOLARA Clinical Trial of BH-30643 for EGFR- and HER2-Mutated Non-Small Cell Lung Cancer

https://www.businesswire.com/news/home/20250122706462/en/BlossomHill-Therapeutics-Doses-Patients-in-the-First-Cohort-of-the-Phase-12-SOLA...

xMEMS XMC-2400: The World’s First 1mm-Thin Active Micro Cooling Fan on a Chip

xMEMS Introduces 1mm-Thin Active Micro Cooling “Fan on a Chip”

Repligen Announces Agreement to Acquire Chromatography Innovator Tantti

Repligen Announces Agreement to Acquire Chromatography (globenewswire.com)

Comments

bottom of page